Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Amgen Inc.    AMGN

AMGEN INC.

(AMGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Amgen : Announces Webcast Of 2020 Third Quarter Financial Results

10/27/2020 | 05:59pm EST

THOUSAND OAKS, Calif., Oct. 27, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its third quarter financial results on Wednesday, October 28, 2020, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 2:00 p.m. PT. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631(media) 
Arvind Sood, 805-447-1060 (investors) 

Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)

 

Cision
View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2020-third-quarter-financial-results-301161178.html

SOURCE Amgen


© PRNewswire 2020
All news about AMGEN INC.
08:58aTakeda Pharmaceutical Company Limited - World's Leading Life Science Companie..
AQ
08:58aAMGEN : Announces New Data Being Presented At ASH 2020
AQ
11/30COVID R&D Alliance launches trial of Amgen, UCB, Takeda drugs
RE
11/30Covid r&d alliance launches trial of amgen, ucb, takeda drugs for hospitalize..
RE
11/28AMGEN : What's Next For U.S. Biosimilar Litigation
AQ
11/26AMGEN : to Present At The Evercore ISI Virtual HealthCONx Conference
AQ
11/25AMGEN : To Present At The Evercore ISI Virtual HealthCONx Conference
PR
11/25AMGEN : On Pace for Eight-Day Losing Streak, Longest Since October 2017 -- Data ..
DJ
11/24AMGEN : to Transition Development and Commercial Rights for Omecamtiv Mecarbil a..
AQ
11/23AMGEN : Ending Heart-Failure Collaboration With Cytokinetics
DJ
More news